H. Richards

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study

Kim Papp, Richard G. Langley, Bárður Sigurgeirsson et al. · British Journal of Dermatology · 2012 · 357 citations

Life Sciences, Dermatology, Immunology +17

Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane

Minoru Satoh, H. Richards, Victoria M. Shaheen et al. · Clinical & Experimental Immunology · 2000 · 131 citations · Full text

Life Sciences, Immunology, Pathobiology +16

Up-regulation of IL-18 and predominance of a Th1 immune response is a hallmark of lupus nephritis

Nicola Calvani, H. Richards, Marco Tucci et al. · Clinical & Experimental Immunology · 2004 · 120 citations · Full text

Medicine, Immunology, Nephrology +17

Overexpression of interleukin-12 and T helper 1 predominance in lupus nephritis

Marco Tucci, Lucia Lombardi, H. Richards et al. · Clinical & Experimental Immunology · 2008 · 114 citations · Full text

Medicine, Immunology, Nephrology +17

High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk

Elena V. Barnes, Sonali Narain, Antonio Naranjo et al. · Lupus · 2005 · 100 citations

Life Sciences, Clinical Sciences, Internal Medicine +17